Abstract

Mini Review

Oncocardiology: Far beyond the cardiotoxicity

Jing Wei, Wen-Jie Pan and Min Pan*

Published: 29 November, 2022 | Volume 7 - Issue 3 | Pages: 098-099

Approximately 73.4% of global deaths are caused by chronic non-communicable diseases, among them, cardiovascular and cerebrovascular diseases, tumors, and chronic respiratory diseases ranked in the top 3 respectively [1]. An accumulating body of evidence showed that the risk of all-cause mortality in cancer patients with cardiovascular disease (CVD) was 3.78 times higher than that of those without CVD and 8.8% of cancer survivors died of CVD [2]. Heart failure (HF) is a serious manifestation or terminal stage of various heart diseases. Although myocardial damage and dysfunction are the main causes of HF, the cardiovascular injury caused by the tumor itself and the detrimental effect of cancer treatment also play an important role. More recently, the data has suggested that up to 25% - 30% of patients with HF have histories of cancer for about 10 years; and cancer also determines the prognosis of heart HF [3]. 

Read Full Article HTML DOI: 10.29328/journal.jccm.1001141 Cite this Article Read Full Article PDF

References

  1. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3. Erratum in: Lancet. 2019 Jun 22;393(10190):e44. PMID: 30415748; PMCID: PMC6252083.
  2. Suzuki T, Yazaki Y, Voors AA, Jones DJL, Chan DCS, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Zwinderman AH, Metra M, Ng LL. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF. Eur J Heart Fail. 2019 Jul;21(7):877-886. doi: 10.1002/ejhf.1338. Epub 2018 Oct 29. PMID: 30370976.
  3. Christiansen MN, Køber L, Torp-Pedersen C, Gislason GH, Schou M, Smith JG, Vasan RS, Andersson C. Preheart failure comorbidities and impact on prognosis in heart failure patients: a nationwide study. J Intern Med. 2020 Jun;287(6):698-710. doi: 10.1111/joim.13033. Epub 2020 Feb 26. PMID: 32103571.
  4. Yeh ET, Chang HM. Oncocardiology-Past, Present, and Future: A Review. JAMA Cardiol. 2016 Dec 1;1(9):1066-1072. doi: 10.1001/jamacardio.2016.2132. PMID: 27541948; PMCID: PMC5788289.
  5. Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group, Lancellotti P, Thuny F, Abdelhamid M, Aboyans V, Aleman B, Alexandre J, Barac A, Borger MA, Casado-Arroyo R, Cautela J, Čelutkienė J, Cikes M, Cohen-Solal A, Dhiman K, Ederhy S, Edvardsen T, Fauchier L, Fradley M, Grapsa J, Halvorsen S, Heuser M, Humbert M, Jaarsma T, Kahan T, Konradi A, Koskinas KC, Kotecha D, Ky B, Landmesser U, Lewis BS, Linhart A, Lip GYH, Løchen ML, Malaczynska-Rajpold K, Metra M, Mindham R, Moonen M, Neilan TG, Nielsen JC, Petronio AS, Prescott E, Rakisheva A, Salem JE, Savarese G, Sitges M, Ten Berg J, Touyz RM, Tycinska A, Wilhelm M, Zamorano JL. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244. PMID: 36017568.
  6. Lipshultz SE, Landy DC, Lopez-Mitnik G, Lipsitz SR, Hinkle AS, Constine LS, French CA, Rovitelli AM, Proukou C, Adams MJ, Miller TL. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol. 2012 Apr 1;30(10):1050-7. doi: 10.1200/JCO.2010.33.7907. Epub 2012 Mar 5. PMID: 22393080; PMCID: PMC3341149.
  7. Khamis A, Shaban AE, Altamimi TS, Shkoukani ZW, Hamam I. Atrial fibrillation in cancer patients who develop stroke. Cardiooncology. 2022 May 18;8(1):12. doi: 10.1186/s40959-022-00137-y. PMID: 35585638; PMCID: PMC9116009.
  8. Nagane M, Yasui H, Kuppusamy P, Yamashita T, Inanami O. DNA damage response in vascular endothelial senescence: Implication for radiation-induced cardiovascular diseases. J Radiat Res. 2021 Jul 10;62(4):564-573. doi: 10.1093/jrr/rrab032. PMID: 33912932; PMCID: PMC8273807.
  9. Barcena ML, Aslam M, Pozdniakova S, Norman K, Ladilov Y. Cardiovascular Inflammaging: Mechanisms and Translational Aspects. Cells. 2022 Mar 16;11(6):1010. doi: 10.3390/cells11061010. PMID: 35326461; PMCID: PMC8946971.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?